Redx Pharma PLC (LON:REDX) insider Iain Ross bought 102,000 shares of Redx Pharma stock in a transaction on Friday, December 22nd. The shares were acquired at an average price of GBX 21 ($0.28) per share, for a total transaction of £21,420 ($28,640.19).
Iain Ross also recently made the following trade(s):
- On Tuesday, November 14th, Iain Ross acquired 348,000 shares of Redx Pharma stock. The stock was purchased at an average cost of GBX 18 ($0.24) per share, for a total transaction of £62,640 ($83,754.51).
Shares of Redx Pharma PLC (REDX) opened at GBX 20 ($0.27) on Thursday. Redx Pharma PLC has a 52-week low of GBX 17.10 ($0.23) and a 52-week high of GBX 46.75 ($0.63). The company has a market cap of $23.89 and a P/E ratio of -2,000.00.
Redx Pharma Plc, formerly Redx Pharma Ltd, is engaged in drug discovery, pre-clinical development and licensing. The Company is engaged in drug discovery across cancer, infection and autoimmune diseases. The Company has over two programs in its oncology research activity, Smoothened Hedgehog (SMO) and Bruton’s Tyrosine Kinase (BTK), which has reached candidate nomination stage.
What are top analysts saying about Redx Pharma? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Redx Pharma and related companies.